Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2016-10-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary endpoint is the quality of life at the end of life and the secondary endpoint is the quality of dying. Both according a numerical rating scale.
An explorative analysis will be done for differences for the hospitals in Groningen, effect of using the Liverpool care Pathway for the dying, effect of using consultation by the palliative consultation team, effect of using the Hospice@UMCG intervention, correlation with the quality of life at the end of life and quality of dying according to nurses and doctors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of the Care Programme for the Last Days of Life
NCT01890239
Quality Improvement Project for Advance Care Planning Tool in Hospital Medicine
NCT04296136
Improving Quality of Care for the Dying Patient in Hospice: A Quasi Experimental Trial in Liguria Region
NCT01470625
An Intervention to Improve End of Life Decision Making Among Homeless Persons
NCT00471016
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
NCT07182357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Shortly after the patient died at the hospital, also the nurse and doctor of this patient are requested to fill out a questionnaire.
The questionnaire for the bereaved relatives consists of items, divided in groups: a general part, followed by questions of the last days of life, existing symptoms (physical, psychological, existential and social), the care and treatment and the loss.
The questionnaire for the nurses exists of similar items. Special attention for recognizing the impending dying and problems, care and therapy at the end of life.
In all questionnaires there are also 2 main questions: What is your opinion of the quality of life during the last days of life and What is your opinion of the quality of dying.
In the three hospitals the end of life care is managed at somehow different ways: the use of the Liverpool care Pathway of the dying, the hospice@UMCG intervention and consultation by the palliative team of the hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
University Medical Center Groningen
all patients that died on one of the wards with the exception of children; on several wards the Hospice care will be introduced as an intervention
Hospice care at UMCG
introduction of hospice care facilities on the wards at the UMCG
Martini Ziekenhuis
all patients that died on one of the wards with the exception of children
No interventions assigned to this group
Ommelander ZorgGroep
all patients that died on one of the wards with the exception of children
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospice care at UMCG
introduction of hospice care facilities on the wards at the UMCG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Martini Hospital Groningen
OTHER
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
An KL Reyners, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
UMCG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Groningen
Groningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016pz/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.